Bankinvest invests in unlisted company with IPO dreams

The company Visiopharm plans to enter the stock exchange, and now the Danish asset manager Bankinvest has joined its group of owners.
Photo: Bankinvest/PR
Photo: Bankinvest/PR
BY MORTEN PLESNER

Bankinvest has acquired an owner's share of just under 6 percent in the unlisted company Visiopharm, which is a candidate for going on the stock exchange. Visiopharm, which delves in the area of cancer diagnostics, already counts ATP and the Danish Growth Fund among its investors, writes business daily Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading